Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
ADILAdial Pharmaceuticals(ADIL) Newsfilter·2024-02-28 22:30

CHARLOTTESVILLE, Va., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL, ADILW))) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced patent number 11,905,562 was issued on February 20, 2024 by the United States Patent and Trademark Office. The patent covers the Company's lead investigational new drug product, AD04, and its ability to target the ser ...